Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data
Objective Individuals with autoimmune rheumatic disease (RD) are considered to be at increased risk for infection. However, few US population‐based studies have assessed whether these patients are at increased risk of hospitalization or death due to COVID‐19 compared with those without RD. Methods W...
Guardado en:
Autores principales: | Gabriela Schmajuk, Anna D. Montgomery, Samuel Leonard, Jing Li, Milena Gianfrancesco, Andrea Seet, Zara Izadi, Jinoos Yazdany, Salomeh Keyhani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/888753374c85464cb0a7b871bf0b9465 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009) -
The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
por: Reimold AM
Publicado: (2012) -
Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseases
por: Perez Alamino R, et al.
Publicado: (2012) -
COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Athanasios-Dimitrios Bakasis, et al.
Publicado: (2021) -
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
por: Fabrizio Cantini, et al.
Publicado: (2009)